GRI Bio increases ATM offering capacity to $7.38M, waives Dec 2025 SPA restrictions

GRI Bio, Inc.

Increased ATM capacity by up to $7.38M in common stock; $6.17M already sold under the program.
Waived certain provisions of the Dec 11, 2025 securities purchase agreement to permit additional ATM issuances.
At-the-market offering agreement with H.C. Wainwright & Co. dated May 20, 2024 remains in effect.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.